Advertisement

Topics

The International Myeloma Foundation and the Myelodysplastic Syndromes Foundation Company Profile

20:49 EST 11th December 2018 | BioPortfolio


News Articles [2742 Associated News Articles listed on BioPortfolio]

Treating myelodysplastic syndromes

Prof Hugo Fernandez speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about the treatment of myelodysplastic syndromes. He discusses the various abnormalities and treatments for them, while t...

Kessler Foundation joins international study to improve cognitive dysfunction in MS

(Kessler Foundation) Nancy Chiaravalloti, PhD, and John DeLuca, PhD, have been awarded a $410,000 grant from the Multiple Sclerosis (MS) Society of Canada and the MS Scientific Research Foundation to ...

Machine learning algorithm improves prognisis accuracy for patients with myelodysplastic syndromes

Dr Aziz Nazha gives a press conference at ASH 2018 about the use of machine learning in determining the prognosis of patients with myelodysplastic syndromes. Watch our interview with Dr Nazha here. ...

ASH 2018: Machine learning-based model improves prognosis accuracy for myelodysplastic syndromes

Researchers have presented at ASH 2018 in San Diego the model of using machine learning - a technique for automating the creation of computer models - to develop a new system to predict how long patie...

International Water Foundation One Drop Sets New Record Raising $8. ...

NEW YORK, Sept. 22, 2018 /PRNewswire/ -- International water foundation One Drop, in partnership with Phillips Auction House, is thrilled to announce the success of Read more...

Amgen And MD Anderson Announce Collaboration To Accelerate Early Stage Treatments For Leukemia, Myelodysplastic Syndromes, Multiple Myeloma, Small-Cell Lung And Other Small-Cell Cancers

Efforts to Focus on Pre-Clinical and Clinical Research for up to 16 Early-Stage Programs Across Various Types of Cancer Multi-Year Agreements Build on Long-Term Partnership in Immuno-Oncology, Includ...

Cleveland Clinic expert develops personalized prediction model for Myelodysplastic Syndromes

At the American Society of Hematology Annual Meeting, Cleveland Clinic medical hematologist and oncologist Aziz Nazha, M.D., will present results of a personalized prediction model that surpassed curr...

The Ewing Marion Kauffman Foundation: Entrepreneurship and Success

In this interview, Lesa Mitchell, VP Kauffman Foundation, Ewing Marion Kauffman Foundation, talks to Dr Fintan Walton about: • the Foundation’s origins and its focus on entrepreneurship • its re...

Drugs and Medications [942 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [2016 Associated PubMed Articles listed on BioPortfolio]

The Florence Nightingale Foundation: developing nursing's leaders.

Ursula Ward, Chief Executive, Florence Nightingale Foundation, chiefexec@florence-nightingale-foundation.org.uk , describes the role of the foundation and its plans for the future.

Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated.

Myelodysplastic syndromes are a heterogeneous group of clonal hematopoietic disorders. However, the therapies used against the hematopoietic stem cells clones have limited efficacy; they slow the evol...

An acoustic emission characterization of the failure process of shallow foundation resting on sandy soils.

Shallow foundation is a common foundation type that is usually used for small to medium size structures. The bearing ability and the failure mechanism of shallow foundation are the fundamental concern...

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Author Index.

Clinical Trials [3475 Associated Clinical Trials listed on BioPortfolio]

A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

The study will be conducted in compliance with the International Council on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Pr...

Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

This is an evaluation of the effectiveness of darbepoetin alpha in treating anemia of MDS patients with an International Prognostic Scoring System (IPSS) score of low or intermediate 1.

A Safety and Pharmacology Study of MPDL3280A (Anti-PD-L1 Antibody) Administered Alone or in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

This is a non-randomized, open-label, Phase 1 study of MPDL3280A (anti-PD-L1 monoclonal antibody [mAb] in intermediate/high/very high-risk myelodysplastic syndromes (MDS) patients, as eval...

Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes

RATIONALE: Drugs used in chemotherapy, such as decitabine, work in different ways to stop the growth of myelodysplastic cells, either by killing the cells or by stopping them from dividing...

Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma

RATIONALE: Cytogenetic tests may help predict how cancer will respond to treatment and allow doctors to plan more effective therapy. PURPOSE: This diagnostic trial is studying genetic dif...

Companies [3099 Associated Companies listed on BioPortfolio]

The Myelodysplastic Syndromes Foundation, Inc.

The Myelodysplastic Syndromes Foundation, Inc. is a multi-disciplinary, international organization devoted to the prevention, treatment, and study of the myelodysplastic syndromes...

MDS Foundation

The Myelodysplastic Syndromes Foundation, Inc. is a multi-disciplinary, international organization devoted to the prevention, treatment, and study of the myelodysplastic syndromes...

The International Myeloma Foundation and the Myelodysplastic Syndromes Foundation

The Myelodysplastic Syndromes (MDS) Foundation

The International Myeloma Foundation

Leading myeloma experts will discuss the latest treatment paradigms, coming out of ASH that could deliver the long-term survivors of the future, in a panel discussion moderated by...

More Information about "The International Myeloma Foundation and the Myelodysplastic Syndromes Foundation" on BioPortfolio

We have published hundreds of The International Myeloma Foundation and the Myelodysplastic Syndromes Foundation news stories on BioPortfolio along with dozens of The International Myeloma Foundation and the Myelodysplastic Syndromes Foundation Clinical Trials and PubMed Articles about The International Myeloma Foundation and the Myelodysplastic Syndromes Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The International Myeloma Foundation and the Myelodysplastic Syndromes Foundation Companies in our database. You can also find out about relevant The International Myeloma Foundation and the Myelodysplastic Syndromes Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record